Glycobiarsol
Glycobiarsol (trade name Milibis) is an antiprotozoal agent that has been used in humans[1] as well as in dogs.[2]
Names | |
---|---|
IUPAC name
Glycobiarsol | |
Systematic IUPAC name
Oxobismuthanyl hydrogen [4-(2-hydroxyacetamido)phenyl]arsonate | |
Other names
[4-[(2-Hydroxyacetyl)amino]phenyl]-oxobismuthanyl-oxyarsinic acid | |
Identifiers | |
3D model (JSmol) |
|
ChemSpider | |
ECHA InfoCard | 100.003.767 |
EC Number |
|
KEGG | |
PubChem CID |
|
UNII | |
CompTox Dashboard (EPA) |
|
| |
| |
Properties | |
C8H9AsBiNO6 | |
Molar mass | 499.063 g·mol−1 |
Pharmacology | |
P01AR03 (WHO) QP51AD03 (WHO) | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
Infobox references | |
References
- Berberian, D. A. (1954). "The trichomonacidal activity of milibis (glycobiarsol)". New York State Journal of Medicine. 54 (22): 3102–3105. PMID 13214428.
- Kibble, R. M. (1969). "Glycobiarsol for the control of Trichuris vulpis infection in the dog". Australian Veterinary Journal. 45 (8): 387. doi:10.1111/j.1751-0813.1969.tb06633.x. PMID 5389346.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.